[1] Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71: 7-33. [2] Weiss GJ, Waypa J, Blaydorn L, et al. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)[J]. Br J Cancer, 2017, 117: 33-40. [3] Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma[J]. Nature, 2011, 474: 609-615. [4] Van den eijnde SM, Van den hoff MJ, Reutelingsperger CP, et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation[J]. J Cell Sci, 2001, 114: 3631-3642. [5] Miyoshi N, Ishii H, Mimori K, et al. ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer[J]. Oncol Rep, 2010, 23: 505-510. [6] 尹婕,潘凌亚,温仪萍,等. 人上皮性卵巢癌细胞系侧群细胞的肿瘤干细胞样细胞生物学特性及膜蛋白差异表达的鉴定[J]. 基础医学与临床, 2022, 42: 221-227. [7] Andersen JP, Vestergaard AL, Mikkelsen SA, et al. P4-ATPases as phospholipid flippases-structure, function, and enigmas[J]. Front Physiol, 2016, 7: 275.doi:10.3389/fphys.2016.000275. [8] Takatsu H, Tanaka G, Segawa K, et al. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane[J]. J Biol Chem, 2014, 289: 33543-33556. [9] Takatsu H, Baba K, Shima T, et al. ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner[J]. J Biol Chem, 2011, 286: 38159-38167. [10] Moreno-smith M, Halder JB, Meltzer PS, et al. ATP11B mediates platinum resistance in ovarian cancer[J]. J Clin Invest, 2013, 123: 2119-2130. [11] Lopez-marques RL, Theorin L, Palmgren MG, et al. P4-ATPases: lipid flippases in cell membranes[J]. Pflugers Arch, 2014, 466: 1227-1240. [12] Saito K, Fujimura-kamada K, Furuta N, et al. Cdc50p, a protein required for polarized growth, associates with the Drs2p P-type ATPase implicated in phospholipid translocation in Saccharomyces cerevisiae[J]. Mol Biol Cell, 2004, 15: 3418-3432. [13] Munoz-martinez F, Torres C, Castanys S, et al. CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells[J]. Biochem Pharmacol, 2010, 80: 793-800. |